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Differentiations prepared from C. elegans FAC-sorted embryonic intestine cells (8E–16E cell
stage), from total embryos and from puriﬁed oocytes, and taking advantage of the NextDB in situ hybridi-
zation data base, we deﬁne sets of genes highly expressed from the zygotic genome, and expressed either
exclusively or preferentially in the embryonic intestine or in the intestine of newly hatched larvae; we had
previously deﬁned a similarly expressed set of genes from the adult intestine. We show that an extended
TGATAA-like sequence is essentially the only candidate for a cis-acting regulatory motif common to intestine
genes expressed at all stages. This sequence is a strong ELT-2 binding site and matches the sequence of
GATA-like sites found to be important for the expression of every intestinal gene so far analyzed experi-
mentally. We show that the majority of these three sets of highly expressed intestinal-speciﬁc/intestinal-
enriched genes respond strongly to ectopic expression of ELT-2 within the embryo. By ﬂow-sorting elt-2(null)
larvae from elt-2(+) larvae and then preparing Solexa/Illumina-SAGE libraries, we show that the majority
of these genes also respond strongly to loss-of-function of ELT-2. To test the consequences of loss of
other transcription factors identiﬁed in the embryonic intestine, we develop a strain of worms that is RNAi-
sensitive only in the intestine; however, we are unable (with one possible exception) to identify any other
transcription factor whose intestinal loss-of-function causes a phenotype of comparable severity to the
phenotype caused by loss of ELT-2. Overall, our results support a model in which ELT-2 is the predominant
transcription factor in the post-speciﬁcation C. elegans intestine and participates directly in the transcrip-
tional regulation of the majority (N80%) of intestinal genes. We present evidence that ELT-2 plays a central
role in most aspects of C. elegans intestinal physiology: establishing the structure of the enterocyte, regu-
lating enzymes and transporters involved in digestion and nutrition, responding to environmental toxins
and pathogenic infections, and regulating the downstream intestinal components of the daf-2/daf-16 path-
way inﬂuencing aging and longevity.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe intestine represents the entire endoderm of the nematode
C. elegans and is clonally derived from a single cell (the E cell) presentus College, Buffalo, New York
l rights reserved.in the 8-cell embryo (Sulston et al., 1983). The intestine shows a
limited degree of spatial patterning but does not partition into distinct
cell types. In keeping with the simple cell lineage and anatomy of the
intestine, the regulatory pathway that speciﬁes intestine fate and
subsequent differentiation also appears relatively simple and straight-
forward (McGhee, 2007; Maduro, in press).
Speciﬁcation of the E cell, the clonal progenitor of the intestine,
corresponds to the activation, probably by direct action of the
maternally-provided transcription factor SKN-1, of genes encoding
the redundant GATA-type transcription factors END-1 and END-3 (Zhu
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end-1/3 is transient. However, before decaying at ∼mid-embryogen-
esis (Zhu et al., 1997, 1998; Baugh et al., 2003), END-1/3 activate genes
expressed in the early endoderm, as well as genes encoding three
additional GATA-type transcription factors: ELT-2, ELT-4 and ELT-7
(C18G1.2) (Fukushige et al., 1998; Zhu et al., 1998; Maduro and
Rothman, 2002; Fukushige et al., 2003). Animals that lack elt-2 arrest
as newly hatched larvae with malformed intestines (Fukushige et al.,
1998). In contrast, elt-7(null); elt-4(null) doubly homozygous animals
are essentially wildtype (McGhee et al., 2007). Thus, ELT-2 appears to
be the only essential GATA-type transcription factor present in the
C. elegans endoderm, following END-1/3 decay. ELT-2 can ﬁrst be
detected when the embryonic endoderm has only two cells (mid-2E
cell stage) and, at least in part because of autoregulation, elt-2 ex-
pression continues in the intestine throughout the life of the worm
(Fukushige et al., 1998, 1999).
We have previously characterized genes, identiﬁed by Serial
Analysis of Gene Expression (SAGE) (Velculescu et al., 1995), that are
expressed speciﬁcally (or highly preferentially) in the adult intestine
(McGhee et al., 2007). Building on two decades of experimental
analysis of intestinal promoters, by ourselves and by others, our
results suggested that the majority of intestinal genes are directly
controlled by ELT-2; (genes encoding ribosomal proteins were noted
as possible exceptions (McGhee et al., 2007)). In the present paper, we
test this model using sets of (non-ribosomal) genes expressed
exclusively (or preferentially) in the embryonic intestine and in the
early larval intestine. We ask: (i) does ELT-2 indeed directly control
the majority of genes expressed at any stage of the developing in-
testine, and; (ii) can we identify any other intestinal transcription
factor of comparable importance to ELT-2?
How is a developmentally-necessary transcription factor, such as
ELT-2, utilized in regulating the many genes that function in the
mature terminally-differentiated organ? This is an especially impor-
tant question to ask about the intestine, which plays such a central
role in the diverse metabolic and homeostatic pathways deﬁning
C. elegans physiology (Ashraﬁ et al., 2003; Kniazeva et al., 2004; Van
Gilst et al., 2005a,b; Rajagopal et al., 2008). The intestine is also a
particularly effective site of action of the DAF-16/FOXO factor, the
major downstream effector of the daf-2-insulin/insulin-like growth
factor signaling pathway inﬂuencing aging and longevity (Libina
et al., 2003). As part of the daf-2/daf-16 dauer pathway, signals pass
between the intestine and the rest of the animal, presumably to
coordinate morphological and physiological responses (Berman and
Kenyon, 2006; Rottiers et al., 2006; Gerisch et al., 2007; Murphy
et al., 2007). The intestine also plays major roles in the response of
C. elegans to environmental stresses, both toxins and infections
(Couillault and Ewbank, 2002; An and Blackwell, 2003; Nicholas and
Hodgkin, 2004; Schulenburg et al., 2004; An et al., 2005; Inoue et al.,
2005; Tullet et al., 2008). There is suggestive evidence that ELT-2
functions in all the above pathways: for example, ELT-2 has been
implicated in the direct control of a number of individual genes
involved in digestion, assimilation and metabolism (Britton et al.,
1997; Fukushige et al., 1998, 2005; Oskouian et al., 2005; Romney
et al., 2008), response to environmental toxins (Moilanen et al.,
1999), response to infection with pathogens (Kerry et al., 2006;
Shapira et al., 2006) and even in the control of a noncoding RNA
induced by starvation (Hellwig and Bass, 2008). With the large data
sets of the present paper, we are now in a position to provide a
more comprehensive analysis of ELT-2 function within both the
developing and the mature intestine. We suggest that ELT-2 plays
central and critical roles in establishing the structure and function
of the enterocyte, producing enzymes required for digestion, assi-
milation and metabolic homeostasis, regulating genes that allow
the worm to respond to environmental stresses, and regulating the
intestinal components of the daf-2/daf-16 aging/longevity/dauer
pathway.Results
Overall approach
We wish to test the hypothesis that the ELT-2 GATA-factor di-
rectly regulates transcription of the majority of the genes expressed
in the C. elegans intestine, beginning from the mid 2E-cell stage
when ELT-2 ﬁrst appears (Fukushige et al., 1998) and continuing
throughout the lifetime of the worm. The major experimental dif-
ﬁculty in testing such an inclusive model is that most genes
expressed in the intestine are likely to be expressed in other tissues
as well (McGhee et al., 2007). Hence, in ELT-2 gain-of-function or
ELT-2 loss-of-function experiments, the overall animal-wide
response of such intestinally-expressed but not intestinal-speciﬁc
genes will appear blunted, possibly to the point of uncertainty. This
problem is likely to be more severe when investigating genes ex-
pressed in the embryo, because of possible high levels of (uniformly-
distributed) maternal transcripts (Baugh et al., 2003 and see below).
To avoid such limitations, we will identify two sets of genes, one set
expressed exclusively/preferentially in the embryonic intestine and
the second set expressed exclusively/preferentially in the early larval
intestine, much as we had previously identiﬁed a (third) set of genes
expressed exclusively/preferentially in the adult intestine (McGhee
et al., 2007). We will then investigate the regulation of these se-
lected gene sets, by searching for common cis-acting regulatory
motifs and by measuring their response to ELT-2 gain-of-function or
loss-of-function. We then extrapolate from the behaviour of these
∼200 intestine-speciﬁc/intestine-enriched genes to the behaviour
of all genes expressed in the C. elegans post-speciﬁcation intestine,
whether their expression is restricted to the intestine or not.
Deﬁning sets of genes expressed exclusively or preferentially in the
embryonic intestine, and in the L1/L2 larval intestine
SAGE libraries were prepared from FAC-sorted embryonic intes-
tine cells (8E–16E cell stage) identiﬁed by the ﬂuorescence of GFP
expressed under control of the elt-2 promoter (see McKay et al.,
2003b). Companion SAGE libraries were prepared from total embryos
at approximately the same developmental stage, as well as from
puriﬁed fer-1(b232ts) oocytes (Stroeher et al., 1994; Mains and
McGhee, 1999). Curated data (WS170) used in the present study are
available in Supplementary Table 1; primary data are available at
http://elegans.bcgsc.bc.ca. Counting single tags, we identiﬁed 5637,
8535 and 7982 individual genes expressed in the embryonic intes-
tine, the total embryo and puriﬁed oocytes, respectively; if single
tags are ignored, the corresponding number of identiﬁed genes is
3615, 6672 and 6035. The distribution of transcript classes (KOG
categories) is highly similar in all three libraries (Supplementary
Fig. 1A), transcript frequencies in all three libraries follow an ap-
proximate power-law distribution (Supplementary Fig. 1B) and there
is a large overlap (65–85%) between genes expressed in the oocyte
and in the embryonic intestine (as well as between the oocyte and the
total embryo; see also Baugh et al., 2003); there is a lower degree
of overlap (∼20%) between genes expressed in the embryonic and
adult intestine (Supplementary Fig. 1C).
To deﬁne a set of genes transcribed zygotically, at high levels, and
exclusively/preferentially in the embryonic intestine, the following
three ﬁlters were applied to the SAGE data. A candidate gene had to
be: (i) identiﬁed at ≥30 tags (per 100,000) in the embryonic intes-
tine library (as well as present in the total embryo library); (ii)
identiﬁed at b10 tags (per 100,000) in the oocyte library, and; (iii)
≳2-fold enriched in the embryonic intestine library relative to the
total embryo library. These ﬁlters are justiﬁed at greater length in
Supplementary Table 2 and Supplementary Fig. 2. The 82 genes in the
resulting set are brieﬂy annotated in Table 1; expression patterns for
54 of these genes are available either from the literature or from
Table 1
Intestine-speciﬁc/intestine-enriched genes identiﬁed in C. elegans embryos
Gene ID Locus Descriptiona Expression patternb Cellular locationc RNAi phenotyped
in situ Rel Other
Gene regulation
F19B2.5 . Helicase-like transcription factor? I/II + − Cyt Norp
F54C9.1 iff-2 Initiation Factor 5A II + − Cyt Emb, Lva, Gro
C33D3.1 elt-2 Zinc ﬁnger GATA-type transcription factor I/II ++ Ie Nuc Lvl
K07H8.10 . RNA-binding protein − Nuc Emb, Gro
T24H10.7 . bZIP transcription factor (Jun-like) − Nuc Emb
H21P03.1 . Multiprotein bridging factor transcriptional
coactivator
I/II ? +/− − Nuc Norp
Structure of the enterocyte (cytoskeleton, etc.)
T25C8.2 act-5 Actin I/II +++ IIf Cyt Emb, Lvl
F10C1.7 ifb-2 Intermediate ﬁlament protein I/II +++ Ig,h Cyt Norp
F57F4.4 . Multiple ET-modules; ∼gﬁ-1 I +++ − Sec/Ex Sck, Gro
C38H2.2 . Galactosyl transferase (glycocalyx?) III + − Sec/Ex Norp
R04E5.10 ifd-1 Intermediate ﬁlament I/II +++ Ih Cyt Norp
T02C12.1 hum-5 Unconventional myosin heavy chain II +++ − Cyt Norp
R12E2.9 inx-15 Innexin type channel I/II +++ − Mem Ric
B0507.3 . ∼proline-rich actin associated protein I/II +++ − ? Norp
Y54F10AM.8 . ∼ laminin A (basement membrane?) I/II +++ − Sec/Ex Norp
“Metabolism” (digestion, energy conversion, synthesis etc.)
Y57A10C.6 . 3-ketoacyl-CoA-thiolase (sterol carrier protein-x) I/II +++ − Per Norp
R10E11.2 vha-2 Vacuolar ATP synthase subunit c II ++ − ER/Vac Emb, Lva
F07D10.1 rpl-11.2 Ribosomal protein (large subunit) II +++ − Cyt Emb, Lvl, Gro
F37C12.11 rps-21 Small ribosomal subunit S21 protein I/II +++ − Nuc Emb, Lva, Sck
T28H10.3 . Hemoglobinase-type cysteine protease I/II +++ − Vac/Sec Emb(?)
E04F6.3 maoc-1 Peroxisomal dehydratase/hydroxysteroid
dehydrogenase
− Per Age, Esp, Fci
R11H6.1 pes-9 Zinc metallopeptidase II + − Cyt Norp
F44G3.6 skr-3 Component of ubiquitin ligase complex I/II ++ − Nuc Ric, Esp
F25B5.4 ubq-1 Ubiquitin III ++ IIIi Cyt Emb, Lvl
Y116F11B.12 gly-4 Glycosyl transferase I/II +/− − Gol Emb(?)
R05F9.6 . Phosphoglucomutase/phosphomannomutase I/II +/− − Cyt Emb(?)
C47E12.4 pyp-1 Inorganic pyrophosphatase − ER Emb, Lvl, Gro
T06C12.10 cgt-1 Ceramide glucosyltransferase − ER Mem Norp
H22K11.1 asp-3 Aspartyl protease I/II +++ − Sec/Ex Age, Ced
D1009.1 . Very long-chain acyl-coA synthetase/fatty
acid transporter
I/II ++ − ER Norp
Y43F8C.13 . Nucleoside hydrolase I/II +++ − Cyt Norp
VZK822L.1 fat-6 Fatty acid desaturase I/II +/− − ER Mem Emb, Unc, Gro
T27E9.2 . Ubiquinol-cytochrome C reductase hinge protein III + − Nuc Gro(?)
C34F11.3 . Adenosine/AMP deaminase I/II +++ − Nuc Lva, Gro
Transport/binding
Y55B1AR.1 lec-6 Galectin I/II +/− − Cyt Norp
F58G1.4 . Putative nematode speciﬁc extracellular
protein precursor
I/II +++ − Sec/Ex Sck, Gro, Clr
C16H3.2 lec-9 Galectin, galactose binding lectin I/II +++ − Cyt Emb(?)
F10G7.11 . ∼transthyretin − Sec/Ex Norp
F35C5.6 clec-63 C-type lectin I/II +++ − Sec/Ex Norp
K02D7.4 dsc-4 Microsomal triglyceride transfer protein I/II +++ Ij Sec/Ex Gro, Unc
W02D3.5 lbp-6 Lipid binding protein I/II ++ − Cyt Norp
T24C4.4 . ∼calcium channel ? ? ? − ER Mem Norp
ZK484.2 haf-9 ABC-type transporter I/II ++ − PlaMem Norp
VC5.3 npa-1 Polyprotein precursor to lipid carrier (?) I/II ++ − Sec/Ex Norp
T19D12.4 . von Willebrand Factor, type A I/II +++ − ER Mem Esp
F49F1.6 . Secreted surface protein∼metridin-like ShK toxin − Sec/Ex? Norp
F35C5.9 clec-66 C-type lectin I/II ++ − Cyt Norp
M01F1.5 hmit-1.3 Proton-dependent myo-inositol transporter I/II + − PlaMem Norp
Detoxiﬁcation/stress response
R107.7 gst-1 Glutathione S-transferase I/II ++ − Cyt Esp
C06B3.3 cyp-35C1 Cytochrome P450 III +/− − Sec/Ex Norp
T07C5.1 ugt-50 UDP-glycosyl transferase III +/− − Sec/Ex Norp
C45B11.3 dhs-18 Dehydrogenase/reductase, short chain I/II + − Per Norp
C03G6.15 cyp-35A2 Cytochrome P450 − Cyt Fcr
T26C5.1 gst-13 Glutathione S-transferase − Cyt Norp
ZK945.1 . Esterase/beta-lactamase I/II + − ER Mem Norp
M88.1 ugt-62 UDP-glucuronosyltransferase − ER Norp
Unknown/uncharacterized
Y119D3B.21 . ∼acidic leucine-rich nuclear phosphoprotein I/II +++ − Nuc? Sck
W05H9.1 . Putative nematode speciﬁc membrane protein I/II ++ − PlaMem Norp
(continued on next page)i
553J.D. McGhee et al. / Developmental Biology 327 (2009) 551–565
Table 1 (continued)
Gene ID Locus Descriptiona Expression patternb Cellular locationc RNAi phenotyped
in situ Rel Other
F19C7.1 . Unknown/uncharacterized I/II +++ − Sec/Ex Gro
T04C12.1 . Unknown/uncharacterized I/II + − Nuc Norp
C26F1.1 . Unknown/uncharacterized − Nuc(?) Norp
C16B8.3 . Unknown/uncharacterized − Mit Norp
F55B11.4 . Zinc ﬁnger domain − PlaMem Fcr
W02A2.9 . Unknown/uncharacterized − ? ?
C18E9.9 . Unknown/uncharacterized − ER Norp
ZC47.14 fbxa-37 Cyclin-like F-box − Cyt Norp
C33A12.3 . Unknown/uncharacterized − Cyt Norp
B0205.13 . Unknown/uncharacterized − ? ?
T20D3.2 . Unknown/uncharacterized I/II ++ − Sec/Ex Norp
F59B1.2 . Unknown/uncharacterized − Sec/Ex Norp
F45H10.4 drr-1 Unknown/uncharacterized − ER Age
B0464.3 nlp-36 Neuropeptide-like protein − Cyt Norp
F54B8.4 . ∼death Associated associated protein (apoptosis) − Nuc Norp
Y82E9BR.23 . Uncharacterized/unknown − ? ?
Y22D7AL.15 . Unknown/uncharacterized − ER Norp
T22H2.6 ∼granulin precursor I/II ++ − Sec/Ex Norp
C15C7.5 . Unknown/uncharacterized I/II ++ − Nuc Gro, Clr, Fcr
F46G10.1 . Unknown/uncharacterized − ? Norp
Y97E10AR.1 . Unknown/uncharacterized I/II +++ − Cyt Norp
K08D8.6 . CUB-like domain − Sec/Mem Norp
C32H11.4 . ∼CUB like region I/II ++ − Sec/Ex Norp
Y55B1AL.1 Unknown/uncharacterized − ? Norp
a Brief description of possible classes of gene function, emphasizing plausible roles in formation/function of the embryonic endoderm. Within each class, genes are ranked in
descending order of the tag counts in the embryonic intestine (high tag counts come ﬁrst). The designation “∼” is used to signify “shows sequence similarity to”.
b Expression patterns are based ﬁrst and foremost on the compilation of in situ hybridization patterns in NextDB, together with associated reliability judgements as previously
described in McGhee et al. (2007): Class I = intestine is the only (obvious) site of expression; Class II = intestine is the major site of expression with, say, b10% of total expression
intensity detected in other cell types; Class III = intestine is one expression site among others in the animal, and; Class IV = gene is not expressed in the intestine. In addition, we assign
a reliability estimate to the expression data, ranging from "+/-" (perhaps) to "+++" (certain). The “Other” column collects expression data from antibodies or reporters and focuses only
on the embryo. Expression pattern compilations (e.g. Hunt-Newbury et al., 2007; Bamps and Hope, 2008) often do not describe expression patterns within the embryo, even though
expression is clearly intestinal post-hatching.
c Mostly derived from PSORTII predictions compiled by AceView. Experimental determination of intracellular or extracellular location (e.g. from antibodies) take precedence. Cyt =
cytoplasm; Nuc = nucleus; Sec/Ex = secreted/extracellular; Mem =membrane; ER = endoplasmic reticulum; Vac = vacuoles; Per = peroxisome; Mit = mitochondria; PlaMem = plasma
membrane; Gol = Golgi.
d Collected fromWormBase. Only phenotypes that apply to embryo or early larval stages are listed. Phenotypes are listed with themost severe ﬁrst. The designation (?) is meant to
signify that one study has reported a phenotype but other studies have not. Norp = No obvious RNAi phenotype; Emb = Abnormal embryogenesis; Lvl = larval lethality; Lva = larval
arrest; Sck = Sick; Gro = abnormal growth rate; Fcr = fat content reduced; Fci = fat content increased; Ric = aldicarb resistance; Esp = enhanced susceptibility to pathogenic infection;
Age = increased life span; Ced = cell death abnormality; Unc = uncoordinated; Clr = clear.
e Fukushige et al. (1998).
f MacQueen et al. (2005).
g Bossinger et al. (2004).
h Karabinos et al. (2004).
i Stringham et al. (1992).
j Shibata et al. (2003).
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ac.jp/db2/index.php) and the majority (49/54=91%) of these available
patterns are consistent with either exclusive or preferential gene
expression in the embryonic intestine (independent of expression at
other stages); examples are shown in Fig. 1A.
To identify genes expressed strongly and exclusively in the L1/L2
larval intestine, all in situ hybridization patterns in NextDB were
surveyed. Table 2 provides brief annotations for 61 genes whose in situ
patterns were judged unambiguous; representative examples are
shown in Fig. 1B. Although genes in these three highly-expressed sets
were identiﬁed by virtue of their expression at a particular stage, most
of the genes are also expressed at other stages (Supplementary Figs.1C
and 3) but at generally lower intensity. Only a minority of genes that
are highly expressed at one stage are identiﬁed as highly-expressed
at other stages: for example, nine genes appear on both embryo
and larval highly-expressed lists, eight genes on both larval and adult
lists, three genes on both embryo and adult lists, and only one gene
(F58G1.4) appears on all three lists.
Computational analysis reveals an extended TGATAA sequence enriched
in intestine speciﬁc promoters
Computational analysis of co-expressed C. elegans promoters is
capable of identifying over-represented sequences that could poten-tially be common cis-regulatory motifs (Gaudet and Mango, 2002;
Gaudet et al., 2004; Pauli et al., 2006; McGhee et al., 2007). Com-
binations of different computational methods appear to be both
more effective and more reliable than any single method (Tompa et
al., 2005). Thus, (as previously (McGhee et al., 2007)), we searched
for motifs common to intestine promoters using two completely
different algorithms: (1) the determinative “oligoanalysis” word-
counting program of the RSAT collection (van Helden et al., 1998,
2000) (hereafter referred to as RSAT) and; (2) the stochastic iterative
Gibbs-sampling-based MotifSampler program (Thijs et al., 2001). We
analyzed promoters from the three sets of intestine-speciﬁc/intes-
tine-enriched genes: embryonic intestine, L1/L2 intestine and adult
intestine; (this last set was previously analyzed in McGhee et al.
(2007) but has been re-curated to database freeze WS170). The
results are shown as “Sequence Logos” (Schneider and Stephens,
1990) in Fig. 2A, and can be summarized as follows:
(i) An extended TGATAA sequence is returned by both RSAT and
MotifSampler algorithms as essentially the only over-represented
sequence found in any of the three promoter sets; a large majority (80–
100%) of all returned motifs contain this sequence (statistics and
calculation parameters are summarized in Supplementary Table 3). The
next most signiﬁcant returned sequence is an information-poor AG-rich
Fig. 1. Expression patterns in (A) C. elegans embryos, and; (B) L1/L2 larvae, of representative genes annotated in Tables 1 and 2. All images represent in situ hybridization to
endogenous transcripts and are taken from the Nematode Expression Data Base (http://nematode.lab.nig.ac.jp/db2/index.php). Gene identiﬁers are shown for each panel (as are gene
loci if available). Dimensions of C. elegans embryos are ∼30×60 μm; length of L1–L2 larvae are ∼200–400 μm.
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promoters fromC. briggsae leads to similar conclusions (data not shown).)
(ii) Although the core of the most signiﬁcant returned sequence
is TGATAA, substantial sequence information can be detected +/−two
bps from this core. This extended information is summarized as a
Position Frequency Matrix (PFM) shown at the bottom of Fig. 2A.
(iii) This extended TGATAA site agrees remarkably well with the cis-
acting GATA-like sequences experimentally determined to be critical
for the expression of all intestinal genes so far investigated (the bottom
logo in Fig. 2A). This latter data includes the 19 sites from Table 2 of
McGhee et al. (2007), updatedwith four ELT-2 sites recently deﬁned in
the ref-1 and ftn-1 genes (Neves et al., 2007; Romney et al., 2008).
What fraction of intestine-speciﬁc/intestine-enriched genes has
a high-scoring TGATAA site in their promoter? To address this key
question, we used the PFM (Fig. 2A) to identify the highest scoring
10-mer on either strand of each promoter from the three intestinal
gene sets, as well as promoters in the following control gene sets:
three sets of 79 genes selected at random from the C. elegans genome
and three sets of genes expressed exclusively/preferentially in
hypodermis, muscle and neurons; (gene identiﬁers are provided inSupplementary Table 4). Fig. 2B plots the highest single PFM score
found in each promoter as a cumulative distribution function, i.e. the
fraction of all scores in the particular set of promoters that lie at or
below a particular score. For the PFM shown in Fig. 2A, the highest
possible score is 0.83 (corresponding to sequence ACTGATAAGA); as
argued previously (McGhee et al., 2007), sequences with scores
below ∼0.7 may not be functional in driving transcription. Fig. 2B
clearly shows that intestine genes, whether identiﬁed in the em-
bryonic, larval or adult intestine, tend to have higher scoring sites in
their promoters than do control genes: 80–90% of the promoters
in the three intestinal gene sets contain extended TGATAA sites
scoring in the range likely to be biologically relevant, compared to
40–50% (essentially genomic background levels) of the promoters
from the control gene sets. By a conservative non-parametric rank
test (see Materials and methods), the probability that the intestine
PFM scores are drawn from the same population as the control PFM
scores is b10−12. Intestine genes have an average of 1.8 such high
scoring sites per promoter, compared to an average of 0.7 sites in the
control promoters. Pauli et al. (2006) have reported a somewhat
lower degree of enrichment of TGATAA sites in the promoters of
genes expressed (not necessarily exclusively) in the intestine of
L4 larvae.
Table 2
Intestine-speciﬁc/intestine-enriched genes identiﬁed in L1/L2 larvae
Gene ID Locus Description Cellular location RNAi phenotype
Lumenal degradation of macromolecules, digestion etc.
Proteinases
Y39B6A.20 asp-1 Aspartic protease (∼Cathepsin D) Sec/Ex Ced
K12H4.7 . Serine-type peptidase Sec/Ex Norp
C25B8.3 cpr-6 Cysteine protease (∼Cathepsin L) Sec/Ex Norp
F32B5.8 cpz-1 Cysteine protease (∼Cathepsin Z) Sec/Ex Emb, Lva
C52E4.1 cpr-1 Cysteine protease (∼Cathepsin B) Sec/Ex Age
T28H10.3 . Asparaginyl peptidase Vac/Ex ? Emb
F44C4.3 cpr-4 Cysteine protease (∼Cathepsin B) Sec/Ex Norp
F54F11.2 . Neprilysin (thermolysin-like zinc metallopeptidase) Sec/Ex/Mem Norp
W07B8.5 cpr-5 Cysteine protease (∼Cathepsin L) Sec/Ex Norp
F23B2.11 pcp-3 Prolyl-carboxypeptidase Lys Norp
T25B6.2 . Neprilysin (thermolysin-like zinc metallopeptidase) Sec/Ex/Mem Norp
F21F8.7 asp-6 Aspartic protease Sec/Ex Ced
T18H9.2 asp-2 Aspartic protease Mem ? Ced
Carbohydrate hydrolysis, lipases
T21H3.1 . Lipase Sec/Ex Norp
R05F9.12 . Maltase glucoamylase Sec/Ex Norp
Lectins, extracellular binding proteins etc.
F35C5.6 clec-63 C-type lectin Sec/Ex Norp
W04E12.8 clec-50 C-type lectin Sec/Ex Norp
W04E12.6 clec-49 C-type lectin Sec/Ex Norp
Detoxiﬁcation and stress response
F01D4.2 ugt-44 UDP-glucuronosyl-transferase Mem Norp
ZK484.2 haf-9 Half transporter (PGP related)/ABC-transporter PlaMem/Mem Norp
W04C9.1 haf-4 Half transporter (PGP related)/ABC-transporter PlaMem/ER Emb/Gro
Y38F1A.6 . Alcohol dehydrogenase/oxidoreductase Cyt Norp
F21G4.2 mrp-4 Multidrug resistance protein family Mem Norp
Y54G11A.5 ctl-2 Catalase Per Emb, Lva, Gro
Y54G11A.6 ctl-1 Catalase Cyt Emb, Lva, Gro
Metabolism and cellular function
F07D10.1 rpl-11.2 Large ribosomal subunit protein Cyt Emb, Lva, Gro
VW02B12L.1 vha-6 Subunit a of vacuolar proton-translocating ATPase Vac/Mem ? Emb/Lva
K04E7.2 opt-2 Oligopeptide transporter PlaMem Gro, Age, Fcr
W02D3.5 lbp-6 Lipid binding protein/fatty acid-binding protein Cyt Norp
R12C12.1 . Glycine decarboxylase Cyt Norp
K02D7.1 . Purine nucleoside phosphorylase Cyt ? Unc
M03A8.1 dhs-28 Short chain dehydrogenase/17-β-OH-steroid dehydrogenase Per Gro
F01G10.1 . Transketolase Cyt ? Emb, Lva, Gro
VC5.3 npa-1 Nematode polyprotein allergen related/lipid carrier (?) Ex/Cyt Norp
C55F2.1 . AICAR transformylase/IMP cyclohydrolase/methylglyoxal synthase Cyt ? Norp
C25F6.3 dpyd-1 Dihydropyrimidine dehydrogenase Cyt ? Norp
F59F4.1 . Acyl CoA oxidase Per Norp
F17E5.1 lin-2 Membrane-associated guanylate kinase (MAGUK) Mem Norp
F22B8.6 . Cystathionine lyase Cyt Norp
T10H9.5 pmp-5 Long chain acyl-CoA transporter/ABC transporter related Per Norp
C55B7.4 acdh-1 (dod-12) Acyl-CoA-dehydrogenase (short-chain) Mit Age, Esp
C27F2.2 nca-2 Calcium channel ? Norp
C56G2.6 let-767 (dhs-10) 17-β-OH steroid dehydrogenase Mit Emb, Lva, Gro
ZK455.1 aco-1 Aconitase Cyt Norp
Unknown function
F19C7.1 . Unknown/uncharacterized ? Emb, Lva, Gro
T07C12.7 ttr-46 Unknown/uncharacterized (transthyretin family domain) Sec/Ex Norp
T02C5.1 . ∼tumour necrosis factor receptor Mem Norp
F58G1.4 dct-18 Unknown/uncharacterized ER Gro, Sck, Clr
T19D12.4 . Unknown/uncharacterized Mem ? Esp
C18B2.5 . Unknown/uncharacterized ? Norp
T25C12.3 . Unknown/uncharacterized (EGF repeats; ∼ lectin C-type domain) Sec/Ex ? Norp
C41G11.4 gnrr-4 Gonadtrophin-releasing_hormone_receptor_related PlaMem Norp
F29G6.3 . Unknown/uncharacterized ? Gro, Sck
T12G3.2 . Unknown/uncharacterized ? Norp
F28B4.3 . Unknown/uncharacterized (EGF repeats) Sec/Ex ? Gro
T19D12.1 . Unknown/uncharacterized (zinc ﬁnger) Mem ? Emb
F57F4.3 gﬁ-1 GEI-4-interacting protein (21 ET modules) Sec/Ex ? Gro
T02E1.3 gla-3 TIS-like protein with zinc-ﬁnger domains (inhibits germline apoptosis) ? Emb, Ste
C43G2.1 . Membrane protein (hemolysin domain) PlaMem ? Norp
Y46E12A.1 cnc-6 Caenacin (secreted antimicrobial peptide ?) Sec Norp
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TGATAA sequence is the only motif identiﬁed as signiﬁcantly over-
represented in all three sets of intestine promoters and hence is the
only current candidate for a cis-acting regulatory motif common to
all intestinally-expressed genes. Although statistical over-represen-tation cannot provide evidence that a motif is functional, such
evidence is provided by the numerous experimental studies that
have identiﬁed extended TGATAA sequences as critical for intestinal
gene expression in C. elegans. Indeed, the computationally derived
PFM can be used to predict the large majority of the GATA sites that
Fig. 2. (A) Sequence logos representing potential cis-acting regulatory sites computa-
tionally identiﬁed as over-expressed sequences in the promoters of intestine genes
expressed in (from top to bottom) C. elegans embryos, L1/L2 larvae and adult. The
sequence logo labeled “Exp't” collects cis-acting GATA sequences experimentally im-
portant for expression of intestine genes (see text). Units of y-axis=bits of information.
“MS” and “RSAT” represent motifs discovered independently by the algorithms
MotifSampler and RSAT Oligoanalysis. Parameters used for calculations are provided in
Supplementary Table 3. The Position FrequencyMatrix (PFM) shown at the bottom of (A)
combines experimental and computational sequence motifs and represents our current
best description of the extended TGATAA sequences proposed to regulate all intestine
genes. (B) Cumulative distribution function of the maximum PFM scores detected on
either strand in each promoter for the seven sets of genes labeled on the ﬁgure.
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cies mostly correspond to the PFM predicting a high scoring site that
was not investigated experimentally).Intestinal genes respond to ectopic expression of ELT-2 within the embryo
Up to the ∼100–200 cell stage of the C. elegans embryo, ectopic
expression of transcriptional activators can drive ectopic expression of
lineage-speciﬁc differentiation markers (Fukushige et al., 1998, 2003,
2006; Horner et al., 1998; Kalb et al., 1998; Zhu et al., 1998; Gilleard
and McGhee, 2001; Maduro et al., 2001, 2005; Fukushige and Krause,
2005). We used this experimental system to test whether intestine-
speciﬁc/intestine-enriched genes respond to ectopic expression of
ELT-2 more strongly than do randomly selected genes or genes
expressed tissue-speciﬁcally but in the hypodermis, muscle or
neurons. As additional controls, we tested the response of the same
gene sets to ectopic expression of END-1 (one of the two GATA factors
associated with endoderm speciﬁcation (Zhu et al., 1997; Maduro
et al., 2005) or either of the two muscle-associated transcription
factors, HLH-1 and PAL-1 (these latter two data sets were described
in Fukushige et al. (2006). Poly-A+ RNA was puriﬁed from embryos at
0 and 6 h following heatshock-induction of the various transcription
factors (see Materials and methods) and analyzed by hybridization to
Affymetrix microarrays. Fig. 3 plots LOG10(Fold-Induction) for the
nine sets of genes responding to the four transcription factors.
Intestinal genes (panels A, B, C) clearly respond more strongly to
ectopic ELT-2 than to ectopic END-1 (pb0.0001 using a conservative
non-parametric rank test) and much more strongly to ELT-2 than to
either of the control factors HLH-1 or PAL-1 (pb10−12). For the set of
genes expressed in the embryonic intestine (panel A), the quantita-
tive responses can be summarized as: ELT-2 (median induction of
7.5-fold; 76% of genes show N2-fold induction); END-1 (median in-
duction of 2.4-fold; 53% of genes show N2-fold induction); HLH-1
(median induction of 1.6-fold; 40% of genes show N2-fold induction);
PAL-1 (median induction of 1.0-fold; 32% of genes show N2-fold
induction). Genes expressed in the embryonic intestine (panel A)
respond more strongly to ectopic ELT-2 than do genes expressed in
the larval intestine (panel B; median induction of 3.5-fold; 65%
N2-fold induction) or adult intestine (panel C; median induction of
1.8-fold; 47% N2-fold induction.) Muscle-speciﬁc genes (panel E) do
not respond to ELT-2 or END-1 but, as expected, respond to ectopic
expression of HLH-1 or PAL-1 (panel E). Other control genes
(hypodermal, neuronal or randomly selected; panels D, F and G–I
respectively) show weak overall responses to any factor.
We interpret the results of this section as consistent with the
hypothesis that ELT-2 directly interacts with the promoters of the
majority of the genes in the intestinal-speciﬁc/intestinal-enriched
sets, in such a way that ELT-2 can drive ectopic expression within the
embryo. We discuss below possible explanations for the minority of
apparently non-responding genes.
Intestinal genes respond to ELT-2 loss-of-function in L1 larvae
To determine what fraction of intestine genes require ELT-2 for
their expression, we constructed a balanced transgenic strain
segregating progeny that are either elt-2(+) or elt-2(ca15), a deletion
allele removing the entire elt-2 coding region (Fukushige et al., 1998).
Strain JM147 elt-2(ca15); [pJM276 (rescuing elt-2(+) genomic plas-
mid); pRF4 (rol-6); pTG96_2 (sur-5::GFP transcriptional fusion
(Yochem et al., 1998))] produces roughly equal numbers of Green
(sur-5::GFP) larvae that are rescued by the wildtype copy of elt-2 on
the transgenic array and Non-Green/elt-2(null) larvae that have lost
the rescuing array and that will therefore arrest (Supplementary
Fig. 4). Embryos were isolated by alkaline-bleach treatment of adult
JM147 hermaphrodites, allowed to hatch overnight in the absence of
food, and the Green/Rescued and Non-Green/elt-2(null) L1 larvae
were separated using a COPAS sorter (see proﬁle in Supplementary
Fig. 4). Three Solexa/Illumina-SAGE libraries were produced and
analyzed: Green/Rescued L1s, Non-Green/elt-2(null) L1s and wildtype
(produced from N2 L1 larvae processed in parallel). The total number
Fig. 3. Fold-Induction (relative increase of hybridization intensity 6 h following heat-shock induction) by ELT-2, END-1, HLH-1 and PAL-1 transcription factors within the early
embryo. Different factors are indicated at the bottom of each panel. Individual gene sets are as follows: (A) embryonic intestine; (B) L1/L2 larval intestine; (C) adult intestine; (D)
hypodermal; (E) muscle; (F) neural; (G–I) three independent randomly selected gene sets. Short horizontal lines represent the response of individual genes in a particular gene set;
short horizontal red line = median response of gene set. Because certain probes are absent from the Affymetrix array, only ∼80–90% of the genes on each list could be tested.
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data are deposited in Supplementary Table 5.
To obtain a quick sense of the validity of the data, we inspected the
tag counts for three genes that should respond to ELT-2 loss and for
which antibodies are available. (i) Tag counts for the elt-2 gene itself
are easily detected in the Green/Rescued library (123 tags per million)
but are essentially abolished in the Non-Green/elt-2(null) library (2
tags per million); this residual tag count provides a measure of back-
ground uncertainty and could reﬂect occasional sequencing errors
or mis-sorted larvae; (ii) the asp-1 gene encodes the major Cathepsin
D-like aspartic protease of the larval intestine (Tcherepanova et al.,
2000); asp-1 tag counts are 18,704 in the normalized Green/Rescued
library, compared to 395 in the Non-Green/elt-2(null) library, a 47-fold
reduction; (iii) the ifb-2 gene encodes an intestine-speciﬁc inter-
mediate ﬁlament (Bossinger et al., 2004); we have shown previously
that loss of ELT-2 does not completely remove IFB-2 from the em-
bryonic intestine (Fukushige et al., 1998), most likely because of prior
activation by END-1/END-3; tag counts for ifb-2 are 1467 in the Green/
Rescued library, compared to 513 in the Non-Green/elt-2(null) library,
a 2.9 fold reduction. The relative intensities of antibody staining in
the intestines of elt-2(+) and elt-2(null) larvae are consistent with
these tag estimates (data not shown).
The overall elt-2 loss-of-function Solexa/Illumina-SAGE data are
displayed as a series of scatter plots in Fig. 4, plotting LOG10(tag count)
for a particular gene in the Green/Rescued library (y-axis) vs. LOG10
(tag count) for the same gene in the Non-Green/elt-2(null) library
(x-axis). Fig. 4A displays the entire data set, after ﬁltering out genesthat show b10 tags in the wildtype control library. Fig. 4B super-
imposes the data points corresponding to a set of genes selected
randomly from the genome, and showing y and x tags in the Green/
Rescued and Non-Green/elt-2(null) library, respectively. As expected,
these points cluster around the scatter plot diagonal, although the
displaced position of several outliers might actually reﬂect loss of
ELT-2: (the red circles in Fig. 4B depict four genes in the randomly-
selected set that happen to be expressed strongly in the intestine.)
Fig. 4C superimposes data points corresponding to genes speciﬁcally
expressed in hypodermis, muscle and neurons. Although these control
data points also cluster around the scatter plot diagonal, they are
further displaced from the diagonal than are the randomly selected
genes shown in Fig. 4B, possibly pointing to real but indirect effects
of loss of ELT-2. Figs. 4D–F superimpose the data points corresponding
to the three sets of genes identiﬁed in the embryonic intestine, larval
intestine and adult intestine, respectively. The principal result of this
section is that genes expressed exclusively/preferentially in the
intestine are displaced further from the diagonal than are genes
from the control sets, either genes chosen at random (Fig. 4B) or genes
expressed exclusively/preferentially in non-intestine tissues (Fig. 4C).
As estimated by a conservative non-parametric rank test (see
Materials and methods), the probability that the data point positions
for intestine and control genes are drawn from the same population
ranges from b0.0001 (embryonic intestine genes compared to
hypodermal, muscle and neuronal genes) down to b10−8 (adult
intestine genes compared to randomly selected genes). We note that,
of the three selected intestinal gene sets, genes expressed in the
Fig. 4. Scatter plots relating LOG10[tag counts in Green/Rescued SAGE library] to LOG10[tag counts in NonGreen/elt-2(null) SAGE library]; both libraries are normalized to one million
tags. Each data point represents an individual gene that has “y” and “x” tags in the Green/Rescued library and Non\Green/elt-2(null) library, respectively. The dashed red lines shown
on each panel are calculated by equation (1) of Audic and Claverie (1997): if the two libraries are identical, 99% of the data points should lie between these boundaries. Panel A shows
all genes with N10 tags in the normalized wildtype library; panel B: superimposes randomly selected genes; red circles mark four genes that happen to be expressed in the intestine;
Panel C: distribution of hypodermal (○), muscle (✖) and neural (●) genes. The remaining three panels represent the distribution of genes expressed in the (D) embryonic; (E) L1/L2
larval, and; (F) adult intestine, respectively.
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2 (Fig. 4D), consistent with END-1/END-3 providing redundant backup
to ELT-2 in the early-to-mid embryo.
Two additional aspects of the ELT-2 loss-of-function data sup-
port the consistency of our analysis. The ﬁrst result is that the set
of ∼400 genes, excluding genes on the intestine-speciﬁc/enriched
lists, displaced farthest above the scatter plot diagonal (i.e. the ∼400
genes that show the largest apparent response to ELT-2 loss-of-
function, with median Green/NonGreen tag ratio=3.4) have a
signiﬁcantly (pb10−5) higher-scoring TGATAA site in their promoters
than do promoters of ∼400 control genes that span the scatter plot
diagonal (i.e. genes that do not respond to loss of ELT-2, with median
Green/NonGreen tag ratio=1.0). This is the result expected if ELT-2
interacts directly in vivo with the promoters of these displaced/ELT-
2-responsive genes. The second result is that the same set of displaced
genes show a signiﬁcantly greater response to ectopic expression of
ELT-2 within the embryo than do the set of genes that span the scatter
plot diagonal (pb10−4).
In summary of this section, the majority of all three sets of highly-
expressed intestinal-speciﬁc/enriched genes respond strongly to
ELT-2 loss. We will discuss below possible explanations for the 10–
20% of genes that do not appear to respond.
Search for other (non-ELT-2) transcription factors with severe
loss-of-intestinal-function phenotypes
Roughly 300 different transcription factors can be identiﬁed in the
embryonic intestine SAGE library (see Supplementary Table 1); we
added to this list a further 18 factors, whose spliced transcripts lack
the CATG site needed to produce a SAGE tag. The large majority of
these factors show no signiﬁcant loss-of-function phenotype, either
by mutation or by RNAi; (we have paid particular attention to the
study of Sonnichsen et al. (2005), in which dsRNA was administered
by maternal injection). However, thirty of these transcription factors
are associated with severe loss-of-function phenotypes such as em-bryonic lethality, larval arrest or developmental delay. To determine
whether loss of any single one of these 30 factors only in the intes-
tine is sufﬁcient to cause these severe phenotypes, we constructed a
strain of worms in which RNAi functions only in the intestine; (see
also Qadota et al., 2007). Strain OLB11 is RNAi-resistant because of a
mutation in the rde-1 gene (Tabara et al., 1999) but intestinal RNAi-
sensitivity has been reconstituted by an integrated transgenic array
in which the rde-1 cDNA is controlled by the elt-2 promoter. Since the
elt-2 promoter is activated at the 2E cell stage (Fukushige et al., 1998),
the OLB11 endoderm should become RNAi-sensitive one cell cycle
after endoderm speciﬁcation but prior to the majority of intestinal
differentiation. Numerous control experiments demonstrate that the
OLB11 strain performs as expected (data collected in Supplementary
Table 6 and Supplementary Fig. 5): developing OLB11 embryos and
larvae appear completely sensitive to RNAi performed (by injection
into mothers) against genes expressed exclusively or predominantly
in the intestine but appear completely resistant to RNAi performed
against non-intestinal genes, including maternal-effect lethal genes
such as skn-1. Immunohistochemistry performed to detect proteins
encoded by RNAi targets veriﬁes the expected loss or major reduc-
tion of intestinal proteins with little effect on non-intestinal proteins;
Fig. 5A shows the intestinal loss but hypodermal-and-pharynx re-
tention of the cell adhesion molecule AJM-1; (we note that animals
lacking intestinal AJM-1 show no obvious phenotype).
Double-stranded RNA corresponding to each of the 30 selected
intestinal transcription factors was injected into hermaphrodites of
strain OLB11, as well as into wildtype (N2) controls (and often into the
rde-1 RNAi-resistant parent strain). We also injected dsRNA corre-
sponding to pop-1 and sbp-1, both of which are known to be expressed
in the intestine but for which no SAGE tags were identiﬁed. For
each transcription factor, embryonic viability, larval viability and
growth rates were measured in the subsequent progeny (Supplemen-
tary Table 6); post-hatching growth rates are shown in Fig. 5B.
The most severe phenotype was a penetrant (90–100%) L1 larval
arrest, observed only for RNAi performed against two transcription
Fig. 5. Use of strain OLB11 (RNAi-sensitive only in intestine) to assay for loss-of-function
phenotypes of intestinally-expressed transcription factors. (A) Demonstration that intes-
tinal markers are RNAi sensitive in strain OLB11 but hypodermal and pharyngeal markers
are not. The top two panels are control uninjected OLB11 embryos, stained for the cell–
cell adhesion molecule AJM-1 (monoclonal antibody MH27) viewed at an interior focal
plane (left) to reveal zig-zag staining pattern bordering the intestine lumen (arrows) and
at a superﬁcial focal plane (right) to reveal hypodermal staining. The bottom two panels
represent OLB11 animals whose mothers were injected with ajm-1 dsRNA. Note lack
of staining in the intestine (arrows) but normal levels of staining in pharynx and hypo-
dermis. In 69 embryos examined, 50% showed no detectable AJM-1 staining in the
intestine, 40% showed weak/reduced intestinal expression and 10% showed essentially
wildtype staining. (B) Relative tip-to-tail length, measured at 3 days post-hatching, of
OLB11 animals whose mothers were injected with double-stranded RNA to the
intestinally-expressed transcription factors, as indicated on the left of the ﬁgure. We
note that arrested OLB11 elt-2(RNAi) larvae are slightly longer than are arrested N2 elt-
2(RNAi) control larvae (lowest bar, designated as N2), consistent with a slight pulse of
ELT-2 produced prior to the onset of intestinal RNAi sensitivity. Error bars represent
standard deviations; average n=13+/−SD=5 worms measured per sample.
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homolog of SREBP1 (sterol response element binding protein),
centrally involved in regulating cholesterol and fatty acid metabolism
(Horton et al., 2002; McKay et al., 2003a; Eberle et al., 2004; Kniazeva
et al., 2004). sbp-1(null) mutants are “pale, skinny, larval-arrested
worms that lack fat stores” (McKay et al., 2003a) but without ob-
viously malformed intestines. The next most severe phenotype was
slow growth post-hatching, associated with RNAi performed against
F57B10.1 (let-607), C16A3.4, and F23B12.7 (see Fig. 5B); RNAi against
dve-1 caused an impenetrant (∼16%) slow growth phenotype.
However, in these last four cases, the slow-growing animals even-
tually develop into fertile adults and the phenotypes are much less
severe than the arrest caused by loss of elt-2 or sbp-1. We also note
that loss of the intestinal functions of either pop-1 or pha-4 only
causes an impenetrant (∼10–20%) embryonic arrest and most
surviving animals appear to grow normally. Intestinal RNAi performed
against the remaining transcription factors shown in Fig. 5B produced
no obvious phenotype.
To summarize the results of this section, we were able to identify
only one transcription factor (besides ELT-2) that is expressed in the
embryonic intestine and that shows a severe intestinal loss-of-
function phenotype, namely SBP-1. Possible limitations in our search
for other intestinal transcription factors will be discussed below.
Discussion
We have previously shown that ELT-2 is the only GATA-type
transcription factor required after the 2E cell stage; worms lacking
both of the two other post-speciﬁcation intestinal GATA factors, ELT-4
and ELT-7, are essentially wildtype (McGhee et al., 2007). It is an
interesting question how such “unnecessary” transcription factors
contribute to endoderm development. We have been completely
unable to detect any phenotype associated with loss of ELT-4
(Fukushige et al., 2003). However, Murray et al. (2008) have recently
reported that loss of ELT-7 function causes a modest (∼23%) decrease
in expression intensity of an endoderm reporter gene, and the pheno-
type of an elt-7(null); elt-2(null) animal is slightly more severe than
the phenotype of an elt-2(null) by itself (unpublished results of
K. Strohmaier and J. Rothman, cited in Maduro and Rothman (2002);
see also Maduro, in press). Both of these observations are consistent
with ELT-7 providing a minor backup function for ELT-2 but do not
challenge our view of ELT-2 preeminence.
Overall, we interpret the present results as supporting a model in
which ELT-2 directly regulates the majority (say N80%) of genes
expressed in the C. elegans intestine, following the early 2E-cell stage
of embryogenesis (McGhee et al., 2007). We focused on the behaviour
of ∼200 highly-expressed intestinal-speciﬁc/intestinal-enriched
genes and showed that the majority of these genes' promoters
contain a high-scoring extended TGATAA site, known to be a strong
ELT-2 binding site; no other candidate for a common cis-acting regu-
latory sequence could be detected. The majority of these ∼200 genes
also respond strongly to ectopic expression of ELT-2 within the
C. elegans embryo and respond strongly to loss of ELT-2 in L1 larvae. In
each of these three assays, 10–20% of the genes did not respond but
we are reluctant to conclude that these latter genes are not controlled
by ELT-2. Such lack of response could simply reﬂect limitations of
the particular assay: for example, a high scoring TGATAA site could
be outside of the limited promoter region scanned, a gene could be
repressed rather than activated by ectopic ELT-2, and loss of ELT-2
in the L1 larva could be masked by a slow turnover of tran-
scripts perduring from an earlier phase of END-1/END-3 activation
in the embryo.
Can we extrapolate from the behaviour of the ∼200 selected
highly-expressed intestinal-speciﬁc/intestinal-enriched genes to the
behaviour of all genes expressed in the C. elegans intestine, including
genes expressed at low levels, or genes for which the intestine is only
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previously (McGhee et al., 2007), promoters of intestine-expressed
ribosomal genes appear to be depleted of TGATAA sequences,
suggesting that they may not fall under ELT-2 control. However,
ignoring ribosomal genes, we suggest that ELT-2 is likely to directly
control intestinal genes independently of their expression levels:
most of the intestinal-speciﬁc/intestine-enriched genes for which
critical TGATAA sites have been experimentally identiﬁed are ex-
pressed at low levels and are not in our selected gene sets. Further-
more, there are ample precedents, both in C. elegans and in other
organisms, for the experimental decomposition of a widely expressed
promoter into a series of independent modular tissue-speciﬁc
enhancers; we draw attention only to the study of Wenick and
Hobert (2004), who deﬁned distinct cis-regulatory regions associated
with gene expression in distinct C. elegans neurons, with the overall
expression pattern of a gene being the sum of the individual patterns.
In other words, we suggest that ELT-2 directly controls expression of
the intestinal component of genes expressed widely in the worm. We
had previously shown that the promoters of genes expressed both in
the intestine and elsewhere in the adult worm are nonetheless
enriched in an extended TGATAA site (McGhee et al., 2007). Overall,
we suggest that a reasonable default position is that, if a gene is
expressed in the post-embryonic intestine, its intestinal expres-
sion will be controlled by ELT-2, unless proven otherwise. An
important test of this view will be whether any gene can be identi-
ﬁed that does not depend on a cis-acting TGATAA-like site for its
intestinal expression.
Our generally unsuccessful search for essential intestinal
transcription factors (other than ELT-2) supports the view that
ELT-2 is indeed the predominant transcription factor driving
differentiation of the post-speciﬁcation intestine. However, our
search strategy had limitations (beyond the usual difﬁculty of
attempting to prove a negative). For example, an intestinal
transcription factor might have no associated SAGE tags because
of low expression level, or the loss-of-function phenotype for a
particular transcription factor could be masked by redundancy (see,
for example, Kirienko et al. (2008)). To answer the ﬁrst objection,
we included transcription factors known to be expressed in the
intestine but which were not detected by SAGE tags (e.g. pop-1
and sbp-1). To partially counter the second objection, we suggest
that the highly efﬁcient response of intestinal genes to ELT-2 loss-
of-function (Fig. 4) makes it unlikely that any second factor will be
redundant with ELT-2. Within these limitations, SBP-1 was the only
other transcription factor (besides ELT-2) whose intestinal loss-of-
function caused a penetrant larval arrest. Because SBP-1 regulates
genes involved in cholesterol and fatty acid homeostasis (McKay et
al., 2003a; Kniazeva et al., 2004), it is tempting to label SBP-1 a
“specialized metabolic” transcription factor whose phenotype could
conceivably be rescued by nutritional supplements, to distinguish it
from a “general developmental” transcription factor such as ELT-2,
which appears to regulate all classes of intestine genes. In support
of this view, we will provide evidence below that ELT-2 may
control the sbp-1 gene directly and then cooperate with SBP-1 in a
feed-forward loop to control genes associated with lipid metabolism.
Although no severe intestinal loss-of-function phenotype could be
detected for the ∼300 transcription factors identiﬁed in the em-
bryonic intestine (besides ELT-2 and SBP-1), we suggest that many
of these factors will act in combination with ELT-2 to regulate sub-
sets of intestinal genes performing particular intestinal functions.
Three clear examples of ELT-2 combining with other transcription
factors are now available: (i) ELT-2 interacts with LAG-1 on the ref-1
promoter as part of the Notch-signaling pathway controlling intes-
tinal morphogenesis (Neves et al., 2007); (ii) ELT-2 activates the
ferritin promoter in combinationwith a second factor that confers iron
responsiveness (Romney et al., 2008), and; (iii) ELT-2 activates the
vit-2 promoter, combining with the MAB-3 protein to confer sex-speciﬁc and tissue-speciﬁc expression of vitellogenins (MacMorris
et al., 1994; Yi and Zarkower, 1999; V. V. Captan, A. M. Danielson and
JDM, unpublished results). Indeed, we suggest that most intestinal
genes will be regulated by combinations of ELT-2 and some other
transcription factor(s).
Fig. 6 summarizes evidence that ELT-2 is directly involved in
many, perhaps most, aspects of C. elegans intestinal physiology: (i)
structure/function of the enterocyte; (ii) digestion/nutrition; (iii)
response to environmental toxins and infections; (iv) aging/long-
evity and the dauer pathway, and; (v) lipid metabolism. Each sector
of Fig. 6 represents one of these pathways and a small number of
candidate ELT-2 target genes have been selected to represent each
pathway. To present the evidence for direct ELT-2 control, each gene
name is associated with a vector whose entries are: (i) the response
of the gene to ELT-2 loss-of-function, i.e. the ratio of tag counts in
the Green/Rescued to NonGreen/elt-2(null) SAGE libraries; (ii) fold
induction in response to ectopic expression of ELT-2 within the
embryo; (iii) a short-hand notation describing the gene's expression
pattern (I = intestinal speciﬁc; II = mostly intestinal with minor
expression elsewhere; III = widespread, including the intestine),
and; (iv) the number of high-scoring potentially-functional ELT-2
binding sites in the gene's promoter; (the expected background
number ∼0.7). Brief explanations will be provided for the gene
assignments for each pathway, emphasizing potential exceptions (or
elaborations) to the proposed predominance of ELT-2.
(i) Structure/function of the enterocyte: The intermediate ﬁlament
protein IFB-2 is a central structural component of the microvillar
brush border (Bossinger et al., 2004). HAF-9 is one of several trans-
porter proteins and could function either extra- or intracellularly
(Sundaram et al., 2008). VHA-6 is an essential subunit of the ATPase
that acidiﬁes either extracellular or intracellular compartments (Oka
et al., 2001). The act-5 gene encodes the major actin component of the
microvillar brush border (MacQueen et al., 2005). act-5 responds
strongly to ELT-2 gain-of-function, has 6 potential ELT-2 binding sites
in its promoter and we would have predicted that act-5 transcripts
would be decreased in the ELT-2 loss-of-function but instead, they are
signiﬁcantly increased. Perhaps, in the absence of growth, ELT-2
represses act-5 transcription.
(ii) Digestion/nutrition: Secreted proteases are the single most pro-
minent class of candidate direct ELT-2 targets: asp-1 (Tcherepanova et
al., 2000) and cpr-1 (Britton et al., 1998) are chosen as two of numerous
possible examples. The opt-2 gene encodes themajor intestinal peptide
transporter and presumably functions to assimilate the products of
luminal proteolysis (Nehrke, 2003; Meissner et al., 2004). We suggest
that ELT-2 directly regulates the genes encoding most of the other
enzymes/proteins secreted into the intestinal lumen, such as saposins
(e.g. spp-1), lysozymes (e.g. lys-1), and lipases (e.g. ZK6.7), whose
collective and probably constitutive function is to digest the bacterial
food.
(iii) Response to toxins and infections: Both Kerry et al. (2006) and
Shapira et al. (2006) have proposed that ELT-2 is centrally involved in
the innate immune response of worms to external pathogens. Indeed,
16 genes were compiled by Wong et al. (2007) on the basis that they
respond to three different pathogens and are expressed in the C.
elegans intestine; 12 of these genes could be identiﬁed in our L1
Solexa/Illumina-SAGE libraries and responded signiﬁcantly to loss of
ELT-2 (pb0.002). C-type lectins form a prominent part of the C. elegans
response to infection (Wong et al., 2007; Schulenburg et al., 2008) and
Fig. 6 presents evidence that two such genes, clec-63 and clec-85,
which are activated in response to a number of different pathogens,
also appear to be regulated by ELT-2. Examples of other classes of
genes identiﬁed in the pathogen response were described as normal
Fig. 6. Summary of evidence supporting the model that ELT-2 is the predominant transcription factor both in intestinal differentiation and in intestinal function. The reverse-
contrast sector on the upper-left of the ﬁgure represents the endoderm speciﬁcation pathway that culminates in activation of the elt-2 gene at the 2E cell stage of embryogenesis.
The ﬁve remaining sectors of the ﬁgure collect several genes representative of major pathways of intestine development or intestine function: each gene on the list is a candidate
direct target of ELT-2. The entries in the vector associated with each gene present the evidence and, from left to right, are: the ratio of tag counts in the Green/Rescued SAGE
library to the tag counts in the NonGreen/elt-2(null) library; the fold induction of the gene caused by ectopic ELT-2 expression within the embryo; intestinal speciﬁcity of gene
expression (see text); the number of high-scoring matches (≥0.7) in each promoter to the PFM of Fig. 2A. Arrows represent proposed direct interactions. For further details, see
text. [⁎]=qualiﬁcations on the presence of TGATAA sites in the promoters: skn-1 is annotated as a downstream gene in an operon and there are no candidate ELT-2 binding sites in
the short intergenic region upstream of skn-1; however, there are four high-scoring sites in the large ﬁrst intron. nhr-49 is also part of an operon; although there are no high-
scoring TGATAA sites in the short intergenic region upstream of nhr-49, there is one such site in the large ﬁrst intron. In addition to the two high-scoring TGATAA sites upstream
of daf-16, there are an additional 10 high-scoring sites in the large (∼13 kb) 5′-intron.
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saposins, lysozymes and lipases). These same classes of genes are
repeatedly identiﬁed as major components of the C. elegans response
to infection, stress and aging and we suggest that ELT-2 provides the
constitutive level of these gene products necessary for normal
digestion. Expression of these genes could then be further stimulated
under particular conditions.
We suggest that the following candidate ELT-2 targets are involved
in protection against toxins in the environment: the mtl-1 metal-
lothionein (Moilanen et al., 1999), cytochrome P450s such as cyp-
37A1, and conjugating enzymes such as ugt-22 and gst-5. Blackwell
and co-workers have shown that zygotic SKN-1 is expressed mainly
in the intestine and is directly involved in controlling genes of the
phase II detoxiﬁcation response (An et al., 2005; Inoue et al., 2005;
Tullet et al., 2008). As shown in Fig. 6, we raise the possibility that
ELT-2 may directly control transcription of at least one of the skn-1
isoforms and then may combine with SKN-1 to control downstream
target genes such as gst-5 (Tullet et al., 2008).
(iv) Aging, longevity and the dauer pathway: The intestine plays a
major role in the aging/longevity/dauer pathway, e.g. as a particularly
effective site of action of the DAF-16/FOXO factor in reversing the
extended lifespans of daf-2 mutants (Libina et al., 2003), and as an
important signaling centre (Berman and Kenyon, 2006; Gerisch et al.,
2007; Murphy et al., 2007). Murphy et al. (2003) have identiﬁed a set
of genes referred to as dod = downstream of daf-16, and have
identiﬁed, besides candidate DAF-16 binding motifs, what they
describe as a “new potential regulatory sequence” over-represented
in dod gene promoters. The sequence, CTTATCA, is the reverse
complement of the highest scoring core sequence present in
intestinal gene promoters (Fig. 2A above) and we thus suggest that
ELT-2 is the “additional, as yet unidentiﬁed, factor” (Murphy et al.,2003) proposed to act in combination with DAF-16 to control
downstream genes in the aging/longevity pathway, at least the
intestinal component of such expression. A cursory inspection of
several dod promoters reveals joint occurrences of DAF-16 sites
(TRTTTAC) and high-scoring TGATAA sites, e.g. an overlapping
TGATAATGTTTAC in the dod-3 promoter; unfortunately, it is not yet
known where most of these genes are expressed. One interesting
gene that is known to be expressed in the intestine is daf-36, which
encodes an enzyme capable of modifying the sterol ligand of DAF-12
(Rottiers et al., 2006); as shown in Fig. 6, we suggest that daf-36
could be a direct ELT-2 target. Also as shown in Fig. 6, we raise the
possibility that ELT-2 directly regulates the transcription of daf-16
isoforms expressed within the intestine.
Budovskaya et al. (2008) have recently reported that a set of age-
responsive genes identiﬁed by spotted microarrays appear to be
signiﬁcantly enriched in genes expressed in the intestine and that
TGATAA-like sites are over-represented in the gene promoters. They
propose that the GATA-factor ELT-3 (together with the primarily-
hypodermal non-intestinal GATA-factors ELT-5 and ELT-6) form a
transcription circuit that guides C. elegans aging. ELT-3 may well
control aging-related genes expressed in the hypodermis and in the
pharyngeal-intestinal and rectal-intestinal valve cells (where ELT-3 is
expressed). However, using anti-ELT-3 antibodies as well as several
different elt-3 transgenic reporter constructs, we found no evi-
dence that ELT-3 is expressed in the intestine, from the embryo up
to mature adulthood (Gilleard et al., 1999; Gilleard and McGhee,
2001). Thus, it is unlikely that ELT-3 directly regulates aging/longevity
genes acting in the intestine and we suggest that ELT-2 is by far the
better candidate.
(v) Lipid metabolism: Three transcription factors important for
C. elegans lipid metabolism have been identiﬁed: the worm SREBP
homolog SBP-1 (McKay et al., 2003a) (see above) and the two nuclear
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(Brock et al., 2006). Both nhr-80 and sbp-1 are expressed exclusively
or highly preferentially in the intestine (Miyabayashi et al., 1999;
McKay et al., 2003a; Kniazeva et al., 2004). In contrast, nhr-49 is
widely expressed in the worm and the intestine is only one of the
major sites of expression (Van Gilst et al., 2005a). Fig. 6 provides
evidence that ELT-2 directly controls the transcription of sbp-1 and
nhr-80, as well as the intestinal component of nhr-49 transcription.
As further suggested in Fig. 6, ELT-2 may also directly control genes
encoding several enzymes of lipid metabolism, possibly in some
combinatorial feed-forward loop with NHR-49, NHR-80 and SBP-1.
We note the unexpected and somewhat contradictory behaviour of
the elo-5 and elo-6 genes. Both genes are expressed in the intestine
(Kniazeva et al., 2004; Pauli et al., 2006; McGhee et al., 2007) and are
likely to be direct targets of SBP-1 (Kniazeva et al., 2004). Although
both promoters have high-scoring TGATAA sites, neither genes appear
to respond to ELT-2 loss-of-function or to ELT-2 gain-of-function
(Fig. 6). On the other hand, mutation of one of the elo-6 TGATAA
sites strongly reduces intestinal expression (Pauli et al., 2006).
Perhaps elo5/elo-6 only respond to ELT-2 at later stages of develop-
ment. In any case, the elo-5/elo-6 promoters would seem to provide an
appropriate experimental system in which the different regulatory
pathways could be distinguished.
The present paper has focused on the later steps in intestine
development, after endoderm speciﬁcation and especially after
hatching. By incorporating these results, the core regulatory pathway
that is required to deﬁne the C. elegans endoderm seems ﬁrm from
start to ﬁnish, at least in outline: from the maternal cytoplasm (skn-1
transcripts) through the intermediate zygotically-produced END-1/
END-3 GATA factors through the GATA-factor ELT-2, which then
directly controls the large majority of the effector genes that provide
the structure and function of the intestine. There appear to be few
other single transcription factors that are necessary. The worm in-
testine thus provides a simple, possibly extreme, model of a trans-
criptional cascade, in which the terminal transcription factor driving
development morphs into a factor that plays a central role in organ
physiology and hence in the overall physiology of the animal. It will
be both interesting and important to determine whether ELT-2 pro-
vides an adequate model for the role of the homologous GATA-factors
in formation and function of the vertebrate endoderm.
Materials and methods
SAGE analysis and bioinformatics
Isolation of elt-2::GFP labeled embryonic intestine cells by FACS
analysis was performed exactly as described in Etchberger et al. (2007)
but using strain JM63 caIs13 [pJM67 (elt-2::GFP/lacZ) (Fukushige et al.,
1999); pRF4 (rol-6(su1006))].
Unfertilized oocytes were produced from strain fer-1(b232) as
previously described (Mains and McGhee, 1999). Production and
analysis of LongSAGE libraries were as described in (McKay et al.,
2003b; Siddiqui et al., 2005; Etchberger et al., 2007; Khattra et al.,
2007;McGhee et al., 2007), using the same quality ﬁlters as inMcGhee
et al., (2007), but with database freeze WS170. Computational analy-
sis of promoters was as described previously (McGhee et al., 2007);
parameter values are collected in Supplementary Table 3.
ELT-2 gain-of-function experiment
Embryonic cell fate conversions were initiated as previously
described (Fukushige et al., 2006). Two cell embryos from transgenic
strains harboring integrated, heat shock promoter driven cDNA for
one of four different transcription factors (ELT-2, END-1, HLH-1, PAL-1)were collected on ice. Embryos were then incubated at room
temperature for a time empirically determined to maximize cell fate
conversion for each factor: 75 min for ELT-2, 60 min for END-1, 60 min
for HLH-1 and 20 min for PAL-1. Embryos were heat shocked at 34 °C
for 30 min and then incubated at room temperature for six hours
prior to collection of RNA (three independent experiments). Indi-
vidual RNA preparations were used to prepare probes that were in-
dependently hybridized to whole genome C. elegans Affymetrix
gene expression arrays, as annotated in WormBase Freeze WS170
(Fukushige et al., 2006). Data was collected and subjected to MAS5.0
(Affymetrix) normalization and imported into GeneSpring for further
analysis. GeneSpring normalizations set all values less than 0.01 to
0.01, each measurement was divided by the 50th percentile of all
measurements in the total sample, and each gene value was divided
by the median of raw values for that gene in all samples. Principle
component analysis of samples was used to identify and eliminate
the most divergent samples for each set; normalized values were
averaged for the two samples of each time point and used to calcu-
late “fold-induction”.
Solexa/Illumina SAGE analysis of elt-2(null) larvae
A Union Biometrica Biosorter equipped with a 488 nm excitation
ﬁlter and a 250 μm ﬂow channel was used to separate Green/Rescued
from Non-Green/elt-2 (null) L1 larvae from the strain JM147. Gravid
adults were subjected to alkaline-bleach treatment, and embryos
were allowed to hatch overnight in M9 buffer in the absence of food
and with vigorous aeration. Larvae were then suspended in M9 and
0.01% Triton X-100 and placed in the Biosorter's sample cup. An initial
gate region utilizing two size parameters, Extinction vs. Time of
Flight, eliminated debris and selected Green or Non-green L1 larvae
(see Supplementary Fig. 4). Collection periods alternated between the
two classes of larvae to ensure exposure to similar conditions. L1
larvae from N2 wildtype worms were collected in parallel as a control.
An aliquot of each population of sorted worms was analyzed by
ﬂuorescence microscopy to ensure sort purity. Solexa/Illumina
libraries were constructed using a LongSAGE protocol (Siddiqui
et al., 2005; Khattra et al., 2007) with modiﬁcations to allow for
direct sequencing on the Illumina 1G Genome Analyzer. Cluster gen-
eration and sequencing was performed on the Illumina cluster station
and 1G analyzer (Illumina) following manufacturer's instructions.
Sequences were extracted from the resulting image ﬁles using the
open source Firecrest and Bustard applications (Illumina) on a 32 CPU
cluster running Red Hat Enterprise Linux 4 (Red Hat) and Sun Grid
Engine 6 (Sun Microsystems). Seventeen bp SAGE tags were ex-
tracted from the resulting reads andmapped to the C. elegans genome.
RNA-mediated interference (RNAi)
Young adult hermaphrodites were injected with dsRNA (1 mg/ml)
prepared using genomic sequences corresponding to each selected
transcription factor (primer sequences available upon request) and
allowed to recover overnight at 20 °C. Offspring produced by each
surviving worm were collected 20–44 h following the injection and
incubated at 20 °C. Viability was measured by counting the number
of eggs laid, unhatched embryos and adults produced from each
injected worm. Growth rates were determined by collecting ∼10–15
RNAi embryos over a 2–3 hour interval and measuring their lengths
24, 48 and 72 h later (20 °C). The strain OLB11 will be described in
detail elsewhere (Bossinger, in preparation).
Statistics
The signiﬁcance of the different behaviours observed with dif-
ferent gene sets was estimated using the conservative Mann–Whitney
rank sum method (Freund, 1962). This test was easily applied to
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inductions” associated with ectopic expression of the different trans-
cription factors (Fig. 3). To compare the response of different sets of
genes to ELT-2 loss-of-function (Fig. 4), the displacement of each gene
from the scatter plot diagonal was calculated as a “probability” using
equation (1) of Audic and Claverie (1997), i.e. the probability that a
gene had “y” and “x” tags in the Green/Rescued and Non-Green/elt-2
(null) libraries, respectively, if the two libraries were identical. This
approach incorporates sampling statistics, unlike the imposition of a
blanket “n-fold” change in tag counts. The probabilities associated
with each gene set were then compared using the Mann–Whitney
rank sum test; the actual probability values were not considered.
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